The ROE as of December 2025 (TTM) for Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) is 9.67%

According to Shanghai MicroPort Endovascular MedTech Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 9.67%. This represents a change of 307.19% compared to the average of 2.38% of the last 4 quarters.

Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) Historical ROE (quarterly & annually)

How has 688016.SS ROE performed in the past?

The mean historical ROE of Shanghai MicroPort Endovascular MedTech Co., Ltd. over the last ten years is 23.07%. The current 9.67% ROE has changed -58.07% with respect to the historical average. Over the past ten years (40 quarters), 688016.SS's ROE was at its highest in in the March 2019 quarter at 18.82%. The ROE was at its lowest in in the December 2024 quarter at -1.35%.

Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) ROE by Quarter and Year

Discovering the peaks and valleys of Shanghai MicroPort Endovascular MedTech Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) Average ROE

How has 688016.SS ROE performed in the past?

The current ROE of Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) ROE vs. Peers

How is 688016.SS’s ROE compared to its peers?

Shanghai MicroPort Endovascular MedTech Co., Ltd.’s ROE is less than LBX Pharmacy Chain Joint Stock Company (6.20%), less than SonoScape Medical Corp. (2.15%), less than Eyebright Medical Technology (Beijing) Co., Ltd. (13.81%), less than Sinocare Inc. (8.38%), less than China National Accord Medicines Corporation Ltd. (2.96%), less than Jafron Biomedical Co.,Ltd. (14.36%), less than Beijing Chunlizhengda Medical Instruments Co., Ltd. (8.81%), less than Xiamen Kingdomway Group Company (11.00%), less than Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (17.27%), less than Sansure Biotech Inc. (3.75%),

Build a custom stock screener for Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai MicroPort Endovascular MedTech Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai MicroPort Endovascular MedTech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.